Liver cancer clinical trials. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy12

Liver Microsomes, Liver Cell Line, Tumor Mitochondria, Liver Hepatocytes Hep G2 Cells Hepatic Artery Neoplastic Stem Cells Tumor Cells, Cultured Bile Ducts, Intrahepatic Portal Vein Cell Line

Organisms6

Mice, Nude Mice, Inbred BALB C Mice, SCID Rats, Inbred F344 Mice, Transgenic Hepatitis B virus

Diseases48

Neoplasms Liver Neoplasms Liver Diseases Carcinoma, Hepatocellular Liver Cirrhosis Breast Neoplasms Prostatic Neoplasms Lung Neoplasms Liver Neoplasms, Experimental Fatty Liver Neoplasm Metastasis Ovarian Neoplasms Stomach Neoplasms Disease Progression Colonic Neoplasms Drug-Induced Liver Injury Neoplasm Invasiveness Cholangiocarcinoma Pancreatic Neoplasms Colorectal Neoplasms Disease Models, Animal Hepatitis B Neoplasm Recurrence, Local Genetic Predisposition to Disease Liver Failure, Acute Cell Transformation, Neoplastic Carcinoma, Non-Small-Cell Lung Liver Abscess Uterine Cervical Neoplasms Carcinoma Liver Diseases, Alcoholic Carcinoma, Squamous Cell Bile Duct Neoplasms Urinary Bladder Neoplasms Liver Cirrhosis, Alcoholic Rectal Neoplasms Precancerous Conditions Hepatitis Esophageal Neoplasms Recurrence Adenocarcinoma Liver Cirrhosis, Experimental Gastrointestinal Neoplasms Hepatitis, Animal Neovascularization, Pathologic Endometrial Neoplasms Occupational Diseases Head and Neck Neoplasms

Chemicals and Drugs42

Drugs, Investigational Antineoplastic Agents Prostate-Specific Antigen RNA, Messenger Tumor Markers, Biological Diethylnitrosamine Cancer Vaccines Aflatoxin B1 Neoplasm Proteins Liver Extracts Placebos alpha-Fetoproteins Fluorouracil Antibodies, Monoclonal Carcinogens Aflatoxins RNA, Small Interfering Antigens, Neoplasm Antineoplastic Agents, Phytogenic Cisplatin DNA, Neoplasm Tumor Suppressor Protein p53 Anticarcinogenic Agents Receptors, Estrogen Receptor, erbB-2 Biological Markers Tamoxifen Thorium Dioxide Paclitaxel MicroRNAs Antimetabolites, Antineoplastic Ethiodized Oil Tumor Suppressor Proteins Antibodies, Monoclonal, Humanized Antineoplastic Agents, Hormonal Plant Extracts Alanine Transaminase Transcription Factors Deoxycytidine Hepatitis B Vaccines Methionine Adenosyltransferase Benzenesulfonates

Analytical, Diagnostic and Therapeutic Techniques and Equipment85

Clinical Trials as Topic Clinical Trials, Phase II as Topic Patient Selection Endpoint Determination Clinical Trials, Phase III as Topic Clinical Trials, Phase I as Topic Research Design Multicenter Studies as Topic Treatment Outcome Randomized Controlled Trials as Topic Liver Transplantation Sample Size Liver Neoplasms, Experimental Sickness Impact Profile Survival Analysis Questionnaires Early Detection of Cancer Antineoplastic Combined Chemotherapy Protocols Reproducibility of Results Data Collection Follow-Up Studies Data Interpretation, Statistical Liver Function Tests Prospective Studies Double-Blind Method Prognosis Survival Rate Controlled Clinical Trials as Topic Risk Factors Retrospective Studies Hepatectomy Risk Assessment Combined Modality Therapy Risk Reverse Transcriptase Polymerase Chain Reaction Registries Gene Expression Profiling Incidence Neoplasm Staging Xenograft Model Antitumor Assays Disease-Free Survival Disease Models, Animal Neoplasm Transplantation Drug Administration Schedule Blotting, Western Odds Ratio Placebos Kaplan-Meier Estimate Sensitivity and Specificity Clinical Protocols Multivariate Analysis Predictive Value of Tests Chemotherapy, Adjuvant Cohort Studies Transplantation, Heterologous Molecular Targeted Therapy Pilot Projects Genetic Therapy Tumor Burden Clinical Trials, Phase IV as Topic Single-Blind Method Drug Therapy, Combination Drug Screening Assays, Antitumor Immunohistochemistry Oligonucleotide Array Sequence Analysis Administration, Oral Polymerase Chain Reaction Models, Biological Early Termination of Clinical Trials Tomography, X-Ray Computed Chemoprevention Severity of Illness Index Transfection Logistic Models Confidence Intervals Random Allocation Drug Delivery Systems Feasibility Studies Flow Cytometry Liver Cirrhosis, Experimental Phytotherapy Chi-Square Distribution Chemoembolization, Therapeutic Immunotherapy Liver, Artificial

Psychiatry and Psychology5

Decision Making Health Knowledge, Attitudes, Practice Physician-Patient Relations Attitude to Health Smoking

Phenomena and Processes36

Liver Regeneration Time Factors Gene Expression Regulation, Neoplastic Dose-Response Relationship, Drug Risk Liver Circulation Cell Proliferation Apoptosis Drug Resistance, Neoplasm Mutation Genetic Predisposition to Disease Odds Ratio Sensitivity and Specificity Cell Survival Signal Transduction Base Sequence Cell Division Down-Regulation Diet DNA Methylation Promoter Regions, Genetic Gene Expression Cell Movement Up-Regulation Transfection Genotype Cell Cycle Tissue Distribution Drug Synergism RNA Interference Polymorphism, Genetic Phenotype Chi-Square Distribution Genetic Vectors Cell Growth Processes Genes, Tumor Suppressor

Disciplines and Occupations7

Mortuary Practice Research Design Medical Oncology Biomedical Research Immunohistochemistry Outcome Assessment (Health Care)Evidence-Based Medicine

Anthropology, Education, Sociology and Social Phenomena4

National Cancer Institute (U.S.)Minority Groups Informed Consent Quality of Life

Humanities1

Quality of Life

Information Science9

Questionnaires Data Collection Data Interpretation, Statistical Survival Rate Internet Registries Incidence Base Sequence Molecular Sequence Data

Named Groups2

Research Subjects Survivors

Health Care59

Clinical Trials as Topic Clinical Trials, Phase II as Topic Patient Selection National Cancer Institute (U.S.)Clinical Trials, Phase III as Topic Patient Participation Clinical Trials, Phase I as Topic Multicenter Studies as Topic Cancer Care Facilities Research Support as Topic Treatment Outcome Randomized Controlled Trials as Topic Eligibility Determination Sample Size Informed Consent Sickness Impact Profile Survival Analysis Questionnaires Reproducibility of Results Data Collection Health Knowledge, Attitudes, Practice Follow-Up Studies Physician-Patient Relations Data Interpretation, Statistical Prospective Studies Attitude to Health Double-Blind Method Survival Rate Controlled Clinical Trials as Topic Risk Factors Retrospective Studies Health Services Accessibility Risk Assessment Risk Registries Incidence Age Factors Disease-Free Survival Odds Ratio Kaplan-Meier Estimate Sensitivity and Specificity Clinical Protocols Multivariate Analysis Predictive Value of Tests Cohort Studies Clinical Trials Data Monitoring Committees Pilot Projects Clinical Trials, Phase IV as Topic Single-Blind Method Early Termination of Clinical Trials Sex Factors Severity of Illness Index Logistic Models Confidence Intervals Random Allocation Cost-Benefit Analysis Feasibility Studies Outcome Assessment (Health Care)Chi-Square Distribution

Geographicals5

United States China Japan Republic of Korea Europe

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Clinical Trials as Topic Clinical Trials, Phase II as Topic Neoplasms Patient Selection National Cancer Institute (U.S.)Endpoint Determination Liver Neoplasms Mortuary Practice Clinical Trials, Phase III as Topic Patient Participation Clinical Trials, Phase I as Topic Research Design Medical Oncology Multicenter Studies as Topic Liver Diseases Carcinoma, Hepatocellular Cancer Care Facilities Drugs, Investigational Liver Minority Groups United States Research Support as Topic Treatment Outcome Antineoplastic Agents Randomized Controlled Trials as Topic Liver Cirrhosis Research Subjects Eligibility Determination Breast Neoplasms Liver Transplantation Sample Size Decision Making Prostatic Neoplasms Lung Neoplasms Informed Consent Liver Neoplasms, Experimental Sickness Impact Profile Liver Regeneration Survival Analysis Biomedical Research Quality of Life Fatty Liver Questionnaires Early Detection of Cancer Antineoplastic Combined Chemotherapy Protocols Microsomes, Liver Reproducibility of Results Data Collection Health Knowledge, Attitudes, Practice Prostate-Specific Antigen Cell Line, Tumor Follow-Up Studies Physician-Patient Relations Data Interpretation, Statistical Liver Function Tests Prospective Studies Time Factors Attitude to Health Double-Blind Method Prognosis Neoplasm Metastasis Gene Expression Regulation, Neoplastic Survival Rate Controlled Clinical Trials as Topic Mice, Nude Internet Risk Factors Ovarian Neoplasms Stomach Neoplasms Disease Progression Colonic Neoplasms Retrospective Studies Mitochondria, Liver Health Services Accessibility Hepatectomy Drug-Induced Liver Injury Hepatocytes RNA, Messenger Hep G2 Cells Neoplasm Invasiveness Dose-Response Relationship, Drug Risk Assessment Combined Modality Therapy Cholangiocarcinoma Tumor Markers, Biological Risk Diethylnitrosamine Liver Circulation Reverse Transcriptase Polymerase Chain Reaction Cancer Vaccines Registries Aflatoxin B1 Pancreatic Neoplasms Gene Expression Profiling Colorectal Neoplasms Cell Proliferation Neoplasm Proteins Incidence Neoplasm Staging Xenograft Model Antitumor Assays

No FAQ available that match "liver cancer clinical trials"